September 18, 2017 09:20 AM EDTUpdated 09:39 AM
News Briefing

Avanir vet Kei­th Katkin takes charge at Urovant; Te­va un­loads as­sets while up­load­ing new CEO

Shehla Shakoor

Managing Director

⇨ Roivant Sci­ences has added an­oth­er sea­soned biotech ex­ec to its sta­ble of CEOs. The um­brel­la group an­nounced this morn­ing that Kei­th Katkin, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times